<html>
  <head>

    <meta http-equiv="content-type" content="text/html; charset=utf-8">
  </head>
  <body bgcolor="#FFFFFF" text="#000000">
    Dear Members of the 3dem group,<br>
    <br>
    please find attached an announcement for a permanent position as
    associated scientist in EM.<br>
    <br>
    Best regards<br>
    <br>
    Denis<br>
    <div class="moz-signature">-- <br>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"
        charset="iso-8859-1">
      <title>NovAliX/signatures</title>
      <style type="text/css">
<!--
Style2 {font-family: Verdana, Arial, Helvetica, sans-serif}
Style3 {color: #669933;font-weight: bold}
-->
</style><span class="Style2">
        <hr color="#99CC00" noshade="noshade" size="4">
        <table border="0" cellpadding="0" cellspacing="0" height="183"
          width="600">
          <tbody>
            <tr>
              <td width="120"><a href="http://www.novalix-pharma.com"><img
                    src="cid:part1.01040806.00030909@novalix-pharma.com"
                    border="0" height="75" width="100" align="top"></a></td>
              <td>
                <table border="0">
                  <tbody>
                    <tr>
                      <td colspan="2" width="300"><font face="Verdana"
                          size="2"><b>Denis ZEYER, PhD<br>
                            Chief Executive Officer</b></font> </td>
                    </tr>
                    <tr>
                      <td colspan="2" width="300"><font face="Verdana"
                          size="2"><b>NovAliX</b><br>
                          Building B: Structural Biology<br>
                          BioParc, bld Sébastien Brant BP 30170<br>
                          F-67405 ILLKIRCH CEDEX<br>
                          FRANCE</font></td>
                    </tr>
                    <tr>
                      <td><font face="Verdana" size="2">tel:</font></td>
                      <td><font face="Verdana" size="2">+33 (0) 368 240
                          011 </font></td>
                    </tr>
                    <tr>
                      <td><font face="Verdana" size="2">fax:</font></td>
                      <td><font face="Verdana" size="2">+33 (0) 368 240
                          016 </font></td>
                    </tr>
                    <tr>
                      <td><font face="Verdana" size="2">email:</font></td>
                      <td><a href="mailto:dz@novalix-pharma.com"><font
                            face="Verdana" size="2">dz@novalix-pharma.com</font></a></td>
                    </tr>
                    <tr>
                      <td><font face="Verdana" size="2">www:</font></td>
                      <td><a href="http://www.novalix-pharma.com"
                          class="moz-txt-link-freetext"><font
                            face="Verdana" size="2">http://www.novalix-pharma.com</font></a></td>
                    </tr>
                  </tbody>
                </table>
              </td>
            </tr>
            <tr>
              <td colspan="2" nowrap="nowrap" valign="top" width="600"
                align="left">
                <dl>
                  <div align="justify"> <br>
                    <dt><font face="Verdana" size="1">CONFIDENTIALITY
                        NOTICE: This e-mail message from NovAliX
                        (including all attachments) is for the sole use
                        of the intended recipient(s) and may contain
                        confidential information. If you are not the
                        intended recipient, please contact the sender by
                        reply e-mail and delete it from your system. Any
                        unauthorized review, use, disclosure, copying or
                        distribution is strictly prohibited. This
                        communication is for general information
                        purposes only and should not be regarded as an
                        official statement of NovAliX. E-mail is
                        susceptible to data corruption, interception,
                        unauthorized amendment, tampering and viruses,
                        and we only send and receive e-mails on the
                        basis that we are not liable for any such
                        corruption, interception, amendment, tampering
                        or viruses or any consequences thereof.<br>
                      </font></dt>
                  </div>
                </dl>
              </td>
            </tr>
          </tbody>
        </table>
      </span></div>
  </body>
</html>